What is the recommended dosing and monitoring for ketamine in an adult patient with acute agitation who has no contraindications such as uncontrolled hypertension, severe cardiac disease, known psychotic disorder, or a history of ketamine abuse?

Ketamine for Acute Agitation: Dosing and Monitoring

For adults with severe undifferentiated agitation requiring rapid sedation, intramuscular ketamine 4-5 mg/kg (or intravenous 1-2 mg/kg administered slowly over 60 seconds) is highly effective, achieving adequate sedation in approximately 6 minutes—significantly faster than traditional agents like haloperidol plus lorazepam.

Recommended Dosing

Intramuscular Administration (Preferred for Agitation)

• Initial dose: 4-5 mg/kg IM 1, 2, 3
• Onset of adequate sedation: 5-8 minutes 1, 3
• Duration of effect: 12-25 minutes 4
• Alternative reduced-dose approach: 2 mg/kg IM may be effective, particularly as second-line therapy after initial benzodiazepine or antipsychotic failure 5

Intravenous Administration

• Initial dose: 1-2 mg/kg IV administered slowly over 60 seconds 4, 2
• Onset: Within 30 seconds to 5 minutes 4
• Critical safety requirement: The 100 mg/mL concentration must be diluted 1:1 with sterile water, normal saline, or D5W before IV administration 4

Repeat Dosing

• If inadequate sedation after 15-20 minutes, may repeat with one-half to full initial dose 4
• Fixed-dose protocols using 250 mg IM have shown 80% efficacy with single administration 6

Essential Monitoring Requirements

Pre-Administration

• Contraindication screening: Uncontrolled hypertension, severe cardiac disease, known psychotic disorders (ketamine may worsen psychosis) 7
• Baseline vital signs when feasible (though 34% of prehospital cases lack pre-administration vitals) 8
• Emergency airway equipment must be immediately available 4

Continuous Monitoring

• Vital signs: Blood pressure, heart rate, respiratory rate, oxygen saturation 4
• Airway patency: Despite preserved airway reflexes, vomiting and aspiration can occur 4
• Respiratory function: Watch for hypoxia (occurs in 15.4% of cases) and airway compromise (14.8%) 8

Expected Hemodynamic Changes

• Transient tachycardia and hypertension are common and typically resolve without intervention 2
• Hypotension, arrhythmias, and cardiac decompensation can also occur 4

Adverse Events and Management

Frequency of Complications

Approximately 30% of patients experience adverse events after ketamine administration 8, though most are manageable:

• Hypoxia: 15.4% 8
• Airway compromise requiring intervention: 14.8% 8
• Secretions/emesis: 7.0% 8
• Intubation rate: 5-10% in emergency department settings 9, 8

Respiratory Support Requirements

When ketamine is used as first-line sedative:

• 19.6% require supplemental oxygen 8
• 11.8% need airway adjuncts (oro/nasopharyngeal airways) 8
• 5.5% require bag-mask ventilation 8
• Advanced airway placement is uncommon but possible 8

Psychiatric Considerations

• Ketamine can induce or worsen psychotic symptoms, particularly in patients with underlying schizophrenia 7
• Effects may be more pronounced and longer-lasting in patients with pre-existing psychotic disorders 7
• Consider co-administration of benzodiazepine to prevent emergence reactions 4

Comparative Efficacy

Ketamine demonstrates superior speed of sedation compared to traditional agents:

• Median time to sedation: 5.8-7.7 minutes with ketamine vs. 11.4-36 minutes with haloperidol/lorazepam 1, 3
• Sedation within 5 minutes: 22% with ketamine vs. 0% with haloperidol/lorazepam 2
• Sedation within 15 minutes: 66% with ketamine vs. 7% with haloperidol/lorazepam 2

However, traditional agents (benzodiazepines, haloperidol, droperidol) remain Level B recommendations for initial treatment of undifferentiated agitation 10. Ketamine is not mentioned in the 2006 ACEP guidelines for adult psychiatric agitation, reflecting its more recent adoption for this indication.

Critical Safety Considerations

High-Risk Scenarios

• Intubation rates are notably higher with ketamine compared to traditional agents, particularly at higher doses 11, 8
• The 2025 geriatric emergency medicine guidelines found midazolam posed elevated risk without efficacy gains, and similar caution applies to ketamine in older adults 11
• Three cardiac arrests were reported in a prehospital series of 313 ketamine administrations 8

Dosing Pitfalls

• Avoid rapid IV bolus: Administer over 60 seconds to prevent respiratory depression and exaggerated vasopressor response 4
• Weight estimation errors: Fixed-dose protocols (250 mg IM) may reduce dosing errors in prehospital settings 6
• Excessive total dosing: Higher cumulative doses prolong recovery time 4

Antisialagogue Consideration

• FDA labeling recommends antisialagogue administration prior to ketamine to reduce secretions 4
• However, this is often impractical in acute agitation scenarios

Clinical Algorithm

1. Verify no contraindications: Severe cardiac disease, uncontrolled hypertension, known psychotic disorder
2. Ensure emergency airway equipment is immediately available
3. Administer ketamine:
   • IM: 4-5 mg/kg (or 2 mg/kg if second-line)
   • IV: 1-2 mg/kg over 60 seconds (dilute 100 mg/mL concentration first)
4. Monitor continuously: Vital signs, airway, respiratory effort, oxygen saturation
5. Prepare for respiratory support: Have oxygen, airway adjuncts, and bag-mask ready
6. Reassess at 15 minutes: Consider repeat half-dose if inadequate sedation
7. Watch for emergence reactions: Consider benzodiazepine if agitation recurs during recovery

The key trade-off is speed versus safety: Ketamine achieves sedation 2-3 times faster than traditional agents but carries higher rates of respiratory complications requiring intervention. This makes it most appropriate for severe, combative agitation where rapid control is essential and airway management capabilities are immediately available.